stockportfolio.pro
Stocks / CVS vs DHR
CVS vs DHR
CVS Health Corporation and Danaher Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| CVS Health Corporation (CVS) | Danaher Corporation (DHR) | |
|---|---|---|
| Market cap | $123.8B | $133.4B |
| Revenue (latest FY) | $402.07B | $24.57B |
| Net income (latest FY) | $1.77B | $3.61B |
| Revenue growth (5y CAGR) | 8.4% | 2.0% |
| Net margin | 0.4% | 14.7% |
| Return on equity | 2.4% | 6.9% |
| P/E ratio | 42.6 | 36.5 |
| Dividend yield | 2.7% | 0.9% |
| Profitable years (of last 10) | 9 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CVS — free Open DHR — freeFrequently asked questions
Which is bigger, CVS or DHR?
Danaher Corporation is larger by market capitalization — $133.4B versus $123.8B.
Which grows faster, CVS or DHR?
Over the last five fiscal years, CVS Health Corporation grew revenue faster — 8.4%/yr versus 2.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.